FDA Considering Retention Bonuses, Lab Improvements To Bolster Expertise
Executive Summary
FDA is seeking funding for employee retention bonuses as a way to stem the migration of competent FDA reviewers to more lucrative jobs in private companies, the agency said.
You may also be interested in...
FDA Quality Assurance Will Catalogue CDER Initiatives To Improve Processes
The Center for Drug Evaluation & Research's quality assurance unit plans to catalogue different initiatives within the center to standardize and improve processes under newly appointed Associate Director for Quality Assurance Mark Goldberger, MD.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011